| 注册
首页|期刊导航|中华医学杂志(英文版)|Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis:A multicenter,randomized,double-blind,placebo-controlled phase 2b trial

Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis:A multicenter,randomized,double-blind,placebo-controlled phase 2b trial

Yan Zhao Furen Zhang Xiaohua Tao Yumei Li Chunlei Zhang Linfeng Li Jianyun Lu Qingchun Diao Qianjin Lu Xiaoyong Man Fuqiu Li Jianzhong Zhang Xiujuan Xia Hao Cheng Yingmin Jia Guoqing Zhao Jinchun Yan Bo Chen Bin Yang Jingyi Li Yangfeng Ding Liming Wu Litao Zhang Jinyan Wang Xiaohong Zhu

中华医学杂志(英文版)2024,Vol.137Issue(2):200-208,9.
中华医学杂志(英文版)2024,Vol.137Issue(2):200-208,9.DOI:10.1097/CM9.0000000000002747

Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis:A multicenter,randomized,double-blind,placebo-controlled phase 2b trial

Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis:A multicenter,randomized,double-blind,placebo-controlled phase 2b trial

Yan Zhao 1Furen Zhang 2Xiaohua Tao 3Yumei Li 4Chunlei Zhang 5Linfeng Li 6Jianyun Lu 7Qingchun Diao 8Qianjin Lu 9Xiaoyong Man 10Fuqiu Li 11Jianzhong Zhang 1Xiujuan Xia 12Hao Cheng 13Yingmin Jia 14Guoqing Zhao 14Jinchun Yan 14Bo Chen 14Bin Yang 15Jingyi Li 16Yangfeng Ding 17Liming Wu 18Litao Zhang 19Jinyan Wang 20Xiaohong Zhu21

作者信息

  • 1. Department of Dermatology,Peking University People's Hospital,Beijing 100044,China
  • 2. Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Veneorology,Shandong First Medical University & Shandong Academy of Medical Sciences,Jinan,Shandong 250022,China
  • 3. Center for Plastic & Reconstructive Surgery,Department of Dermatology,Zhejiang Provincial People's Hospital(Affiliated People's Hospital,Hangzhou Medical College),Hangzhou,Zhejiang 310014,China
  • 4. Department of Dermatology,Affiliated Hospital of Jiangsu University,Zhenjiang,Jiangsu 212001,China
  • 5. Department of Dermatology,Peking University Third Hospital,Beijing 100191,China
  • 6. Department of Dermatology,Beijing Friendship Hospital,Capital Medical University,Beijing 100050,China
  • 7. Department of Dermatology,The Third Xiangya Hospital of Central South University,Changsha,Hunan 410013,China
  • 8. Department of Dermatology,Chongqing Traditional Chinese Medicine Hospital,Chongqing 400011,China
  • 9. Hunan Key Laboratory of Medical Epigenomics,Department of Dermatology,The Second Xiangya Hospital of Central South University,Changsha,Hunan 410011,China
  • 10. Department of Dermatology,The Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou,Zhejiang 310009,China
  • 11. Department of Dermatology,The Second Hospital of Jilin University,Changchun,Jilin 130041,China
  • 12. Department of Dermatology,Qingdao University Medical College Affiliated Yantai Yuhuangding Hospital,Yantai,Shandong 264000,China
  • 13. Department of Dermatology,Sir Run Run Shaw Hospital,School of Medicine,Zhejiang University,Hangzhou,Zhejiang 310016,China
  • 14. Clinical Department,Keymed Biosciences(Chengdu)Limited,Chengdu,Sichuan 610219,China
  • 15. Department of Dermatology,Dermatology Hospital,Southern Medical University,Guangzhou,Guangdong 510091,China
  • 16. Department of Dermatology,West China Hospital,Sichuan University,Chengdu,Sichuan 610041,China
  • 17. Department of Dermatology,Shanghai Skin Disease Hospital,Institute of Psoriasis,Tongji University School of Medicine,Shanghai 200443,China
  • 18. Department of Dermatology,Affiliated Hangzhou First People's Hospital,Zhejiang University School of Medicine,Hangzhou,Zhejiang 310006,China
  • 19. Department of Dermatology,Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital,Tianjin 300120,China
  • 20. Department of Dermatology,Ningbo No.2 Hospital,Ningbo,Zhejiang 315010,China
  • 21. Department of Dermatology,The Wuxi Second Affiliated Hospital of Nanjing Medical University,Wuxi,Jiangsu 214002,China
  • 折叠

摘要

关键词

CM310/Moderate-to-severe atopic dermatitis/Interleukin-4 receptor alpha/Adults

Key words

CM310/Moderate-to-severe atopic dermatitis/Interleukin-4 receptor alpha/Adults

引用本文复制引用

Yan Zhao,Furen Zhang,Xiaohua Tao,Yumei Li,Chunlei Zhang,Linfeng Li,Jianyun Lu,Qingchun Diao,Qianjin Lu,Xiaoyong Man,Fuqiu Li,Jianzhong Zhang,Xiujuan Xia,Hao Cheng,Yingmin Jia,Guoqing Zhao,Jinchun Yan,Bo Chen,Bin Yang,Jingyi Li,Yangfeng Ding,Liming Wu,Litao Zhang,Jinyan Wang,Xiaohong Zhu..Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis:A multicenter,randomized,double-blind,placebo-controlled phase 2b trial[J].中华医学杂志(英文版),2024,137(2):200-208,9.

基金项目

The development of CM310 has been partially funded by the National 13th Five-Year Plan for Major New Drug Development of China(No.2017ZX09302010). (No.2017ZX09302010)

中华医学杂志(英文版)

OACSTPCDMEDLINE

0366-6999

访问量0
|
下载量0
段落导航相关论文